LTRN
Lantern Pharma Inc
NASDAQ: LTRN · HEALTHCARE · BIOTECHNOLOGY
$2.05
+3.54% today
Updated 2026-04-30
Market cap
$27.69M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.57
Dividend yield
—
52W range
$1 – $6
Volume
0.7M
Lantern Pharma Inc (LTRN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+19.2%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+13.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+3.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+15.0%
2026-03-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.36 | — | $1.24 | $1.42 | +15.0% |
| 2025-12-31 | $-0.36 | +21.7% | $3.06 | $3.11 | +1.6% |
| 2025-11-05 | $-0.39 | +11.4% | $3.63 | $3.36 | -7.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | — | $-0.36 | — | — | — |
| 2025-12-31 | $-0.46 | $-0.36 | +21.7% | — | — |
| 2025-09-30 | $-0.44 | $-0.39 | +11.4% | — | — |
| 2025-06-30 | $-0.53 | $-0.40 | +24.5% | — | — |
| 2025-03-31 | $-0.43 | $-0.42 | +2.3% | $100654.00 | — |
| 2024-12-31 | $-0.51 | $-0.54 | -5.9% | $100654.00 | -61.4% |
| 2024-09-30 | $-0.56 | $-0.42 | +25.0% | — | — |
| 2024-06-30 | $-0.55 | $-0.46 | +16.4% | — | — |
| 2024-03-31 | $-0.43 | $-0.51 | -18.6% | — | — |
| 2023-12-31 | $-0.40 | $-0.39 | +2.5% | $261052.00 | — |
| 2023-09-30 | $-0.45 | $-0.29 | +35.6% | — | — |
Frequently asked questions
Has Lantern Pharma Inc beaten earnings estimates?
Lantern Pharma Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +19.2% over the last 3 quarters.
How does LTRN stock react to earnings?
LTRN stock has moved an average of +3.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.